Comments
Lupin on Monday said the US Food and Drug Administration (USFDA) has completed inspection of its Nagpur facility without making any observations. Lupin said its Nagpur facility manufactures oral solid products. Shares of Lupin edged up 0.23 per cent to close at ₹754.20 on the NSE; during intra-day deals, they rose to a high of ₹777.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.